The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease
Senthilkumar S. Karuppagounder(Johns Hopkins University), Han Seok Ko(Johns Hopkins University), Ted M. Dawson(Johns Hopkins University), Valina L. Dawson(Johns Hopkins University), Saurav Brahmachari(Johns Hopkins University), Yunjong Lee(Sungkyunkwan University)
Cited by 259
Related Papers
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
|Cell Death and Differentiation|2018|6.6k
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
|Nature Medicine|2018|1.2k
PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
|Cell|2011|951
PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease
|Molecular Neurodegeneration|2020|484
Induction of Glial Fibrillary Acidic Protein Expression in Astrocytes by Nitric Oxide
|Journal of Neuroscience|2006|381